Skip to content
TrialScanner

NCT04430894

KRDI in Transplant-Eligible MM

Phase 2Active, not recruitingAMGNCollaboratorSNYCollaborator

Registry record

Lead sponsor
Massachusetts General Hospital
Conditions
Multiple Myeloma
Primary completion
Jul 30, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04430894 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04430894: KRDI in Transplant-Eligible MM | TrialScanner